BH4-responsive hyperphenylalaninemia remedies
Details for Australian Patent Application No. 2005239939 (hide)
International Classifications
Event Publications
23 November 2006 PCT application entered the National Phase
PCT publication WO2005/107759 Priority application(s): WO2005/107759
24 May 2007 Change of Name(s) of Applicant(s), Section 104
Daiichi Asubio Pharma Co., Ltd. The name of the applicant has been changed to Asubio Pharma Co., Ltd.
19 August 2010 Alteration of Name
The name of the applicant has been altered to Daiichi Sankyo Company Limited
27 January 2011 Application Accepted
Published as AU-B-2005239939
3 March 2011 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 17 Jan 2011. Address for service in Australia - Phillips Ormonde Fitzpatrick 367 Collins Street Melbourne VIC 3000
30 June 2011 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 17 Jan 2011
30 June 2011 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser